✦ LIBER ✦

A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer

✍ Scribed by Trudel, Suzane; Trachtenberg, John; Toi, Ants; Sweet, Joan; Hua Li, Zhi; Jewett, Michael; Tshilias, John; Zhuang, Li Hue; Hitt, Mary; Wan, Yonghong

Book ID: 110019034
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 271 KB
Volume: 10
Category: Article
ISSN: 0929-1903
DOI: 10.1038/sj.cgt.7700626

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of interleukin-2 and high-

Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer

✍ J. Y. Douillard; J. Bennouna; F. Vavasseur; R. Deporte-Fety; P. Thomare; F. Giac 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 92 KB

Pegfilgrastim supports delivery of FEC-1

Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: A randomized phase 2 trial

✍ G. Romieu; M. Clemens; R. Mahlberg; P. Fargeot; M. Constenla; M. Schütte; V. Eas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Phase I trial of patient-oriented vaccin

Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer

✍ Masanori Noguchi; Kyogo Itoh; Shigetaka Suekane; Akihisa Yao; Norie Suetsugu; Ka 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 358 KB

Vorinostat in advanced prostate cancer p

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) : Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium

✍ Deborah Bradley; Dana Rathkopf; Rodney Dunn; Walter M. Stadler; Glenn Liu; David 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

A Phase I/IB trial of murine monoclonal

A Phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma : A report of the Children's Cancer Group

✍ Jami D. Frost; Jacquelyn A. Hank; Gregory H. Reaman; Sharon Frierdich; Robert C. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Phase I/IB study of the Children's Cancer Group (CCG) and were monitored for toxicities and response

Randomized trial of low-dose interleukin

Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-γ after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer

✍ Vahdat, L T; Cohen, D J; Zipin, D; Lo, K S; Donovan, D; Savage, D; Tiersten, A; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB